Asia
News,Asia,Venture Debt,Singapore
Temasek, DBS jointly launch $500M debt financing platform for Asia’s growth stage tech firms
Headquartered in Singapore, EvolutionX will provide non-dilutive financing to growth stage technology-enabled companies across Asia, with a focus on China, India, and Southeast Asia.
July 30, 2021
News,Gaming,Asia,Mergers and Acquisitions
Animoca Brands acquires indie game developer Blowfish Studios
The current management of Blowfish will continue to operate the company after the acquisition.
July 30, 2021
News,Asia,Investments,Singapore,Blockchain / Crypto
Crypto wealth platform Vauld raises $25M in Series A round led by Peter Thiel’s Valar Ventures
The funding will be used to support the company’s international growth and licensing as well as expand its retail crypto banking and investing platform.
July 30, 2021
News,FinTech,Venture Capital,Asia
Airwallex founders launch new venture capital fund Capital 49, aims to raise $200M
Capital 49 will look for opportunities to invest in companies within Airwallex’s ecosystem, across a number of industries including e-commerce, SaaS, digital and technology, business services and enablers, and FinTech.
July 29, 2021
PE firm Gaw Capital Partners sets up data center JV, with first investment in Batam, Indonesia
In addition to the maiden project in Batam, Data Center First will also work with Gaw Capital Partners to originate, evaluate and develop data center projects in Southeast Asia and beyond.
July 23, 2021
Animoca Brands, Brinc launch Launchpad Luna, an accelerator for NFT startups
The Launchpad Luna accelerator will identify and foster NFT innovation in the fields of culture, art, entertainment, media, gaming, streaming, collectibles, insurance, finance, and data management; DeFi and additional verticals will be added in the future.
July 21, 2021
News,AI,Asia,Biotech / MedTech
Insilico Medicine closes $255M Series C led by Warburg Pincus to further develop AI and drug discovery
Proceeds from the funding will be used to progress Insilico Medicine's current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities, the company added.
June 24, 2021